Peterman, N., Lata, P., Weigel, C., Leon, S., Hout, I., Chan, W., Schmidt, R., Tran, H., Youssef, Y., Scherle, P., Bhagwat, N., Reneau, J., Chung, C., Brammer, J., Wilcox, R., Alinari, L., Baiocchi, R., Hanel, W. (2025). PRMT5 is a therapeutic vulnerability in cutaneous T-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-1529